ProShare Advisors
CVAC

ProShare Advisors’s CureVac CVAC Stock Holding History

ProShare Advisors’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,120
Closed -$28K – 2100
2025
Q1 		$28K Sell
10,120
-507
-5% -$1.76K ﹤0.01% 2007
2024
Q4 		$36.2K Sell
10,627
-2,629
-20% -$7.58K ﹤0.01% 2222
2024
Q3 		$39K Sell
13,256
-591
-4% -$1.95K ﹤0.01% 2004
2024
Q2 		$47.1K Sell
13,847
-1,844
-12% -$6.03K ﹤0.01% 1759
2024
Q1 		$47.5K Buy
15,691
+1,389
+10% +$4.88K ﹤0.01% 1909
2023
Q4 		$60.2K Sell
14,302
-9,528
-40% -$51.7K ﹤0.01% 1843
2023
Q3 		$163K Buy
23,830
+150
+0.6% +$1.32K ﹤0.01% 1530
2023
Q2 		$247K Buy
23,680
+8,291
+54% +$74.2K ﹤0.01% 1408
2023
Q1 		$107K Sell
15,389
-349
-2% -$3.04K ﹤0.01% 1580
2022
Q4 		$94.9K Sell
15,738
-32
-0.2% -$236 ﹤0.01% 1662
2022
Q3 		$124K Buy
15,770
+1,204
+8% +$14K ﹤0.01% 1510
2022
Q2 		$198K Sell
14,566
-4,811
-25% -$79.6K ﹤0.01% 1481
2022
Q1 		$380K Sell
19,377
-6,933
-26% -$138K ﹤0.01% 1471
2021
Q4 		$903K Buy
+26,310
New +$1.06M ﹤0.01% 1080

Other funds holding CVAC

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

ProShare Advisors's CVAC Position: Q2 2025 in Review

ProShare Advisors sold out of CureVac (CVAC) in Q2 2025, closing a stake of 10,120 shares — an estimated $28K sold.

ProShare Advisors first reported a position in CVAC in Q4 2021 and held it in 14 quarters. The position peaked at $903K in Q4 2021. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

  • ProShare Advisors reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
  • ProShare Advisors sold 10,120 CureVac shares in Q2 2025, an estimated $28K.
  • ProShare Advisors first reported a position in CureVac in Q4 2021 and held it in 14 quarters.
  • ProShare Advisors's CureVac position peaked at $903K in Q4 2021.
  • 91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on ProShare Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.